A study with a new ultrasonic scanning technique shows that scanning of the carotid arteries can reveal who is at high risk of being hit by a blood clot.
GE Healthcare received U.S. Food and Drug Administration (FDA) 510(k) clearance of its Q.Clear technology, which is designed to provide up to two times improvement in both quantitative accuracy and image quality in PET/CT imaging.
If you enjoy this content, please share it with a colleague
Coronary artery calcium scoring, a test that measures the amount and pattern of calcium that has accumulated in a patient’s coronary arteries, appears to provide an early indication of a person’s long-term risk for heart disease, according to data from five studies presented at the American College of Cardiology (ACC) 63rd Annual Scientific Session.
If you enjoy this content, please share it with a colleague
Congress recently passed the Protecting Access to Medicare Act of 2014, which requires use of appropriate use criteria (AUC) and clinical decision support (CDS) software to get Medicare reimbursement. This will likely shift focus onto IT vendors who can supply this software. In addition, the use of CDS is part of Stage 2 Meaningful Use requirements for electronic medical records (EMR), so the new Medicare requirements will move CDS up on many IT departments' priority lists.
If you enjoy this content, please share it with a colleague
West Physics acquired Medical Physics Services Inc. (MPS) of Daphne, Ala. MPS has provided diagnostic medical physics testing and consulting services in Alabama, Florida and Mississippi since 1990.
DICOM Grid has been contracted by Greater Houston Healthconnect to electronically deliver medical images to area hospitals and physicians at the point-of-care.
April 7, 2014 — A new multicenter clinical trial seeks to offer men another option for treating prostate cancer, one that physicians hope will treat cancers with fewer side effects. The treatment involves the use of MRI (magnetic resonance imaging) to guide focused beams of ultrasound energy to the prostate.
April 7, 2014 — Cianna Medical announced the results of a retrospective study of breast cancer patients with ductal carcinoma in situ (DCIS) treated with SAVI breast brachytherapy. Researchers reported excellent local control, with recurrence rates that appear to be equivalent to those expected for whole breast irradiation (WBI) with similar follow-up.
